Skip to search formSkip to main contentSkip to account menu

Factor Xa Inhibitor [EPC]

Known as: Factor 10a Inhibitor, Activated Factor X Inhibitor, Activated Factor 10 Inhibitor 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Essentials The value of thrombin generation assay (TGA) in monitoring direct oral anticoagulants (DOAC) is not well defined. TGA… 
2016
2016
Fondaparinux (FPX), a synthesized factor Xa inhibitor, is one of the most popular anticoagulants for the prevention of… 
2016
2016
BackgroundFactor Xa inhibitor is a key drug in the coagulation cascade. Parenteral anticoagulation using low molecular weight… 
2015
2015
Management of intracoronary thrombus in patients presenting more than 12 hours after the onset of ST elevation myocardial… 
Review
2013
Review
2013
Major orthopedic surgery is associated with a high risk of venous thromboembolism (VTE). Anticoagulants are recommended to… 
2013
2013
Background. Darexaban (YM150) is a potent direct factor Xa (FXa) inhibitor developed for the prophylaxis of venous and arterial… 
2013
2013
Objectives: To determine the risk of major clinical and thromboembolic events after cardioversion for atrial fibrillation in… 
2013
2013
The clinical pharmacokinetics, pharmacodynamics, safety and tolerability of darexaban after single and multiple once‐daily doses…